Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Hiemstra

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
BMC Nephrology|August 7, 2012
Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinicCaroline Robinson, Thomas F Hiemstra, Deborah Spencer, et al.
Scientific Reports|January 4, 2017
PDLIM5 links kidney anion exchanger 1 (kAE1) to ILK and is required for membrane targeting of kAE1Ya Su, Thomas F Hiemstra, Yahui Yan, et al.
Nephron|February 28, 2015
Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal diseasePeter A G Galloway, Ragada El-Damanawi, Victoria Bardsley, et al.
Arthritis Research & Therapy|June 9, 2017
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapseMatthew David Morgan, Matthew Szeto, Michael Walsh, et al.
Kidney International Reports|April 29, 2021
Per-Treatment <i>Post Hoc</i> Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKDAndrew J Mallett, Ronald D Perrone, Gopala Rangan, et al.
Kidney International Reports|March 18, 2021
An Evaluation of Commonly Used Surrogate Baseline Creatinine Values to Classify AKI During Acute InfectionDaniel J Cooper, Katherine Plewes, Matthew J Grigg, et al.
Trials|March 14, 2023
PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)Toby J L Humphrey, Davinder Dosanjh, Thomas F Hiemstra, et al.
American Journal of Physiology. Renal Physiology|October 29, 2010
Glyceraldehyde 3-phosphate dehydrogenase is required for band 3 (anion exchanger 1) membrane residency in the mammalian kidneyYa Su, Katherine G Blake-Palmer, Andrew C Fry, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2015
α-Klotho Expression in Human TissuesKenneth Lim, Arnoud Groen, Guerman Molostvov, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2025
Pharmaceutical Practice Considerations Regarding Adoption of the Race-Free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 EquationsRuth Tarzi, Jennifer McKenzie, Michel Reid, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
BMC Nephrology|August 7, 2012
Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinicCaroline Robinson, Thomas F Hiemstra, Deborah Spencer, et al.
Scientific Reports|January 4, 2017
PDLIM5 links kidney anion exchanger 1 (kAE1) to ILK and is required for membrane targeting of kAE1Ya Su, Thomas F Hiemstra, Yahui Yan, et al.
Nephron|February 28, 2015
Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal diseasePeter A G Galloway, Ragada El-Damanawi, Victoria Bardsley, et al.
Arthritis Research & Therapy|June 9, 2017
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapseMatthew David Morgan, Matthew Szeto, Michael Walsh, et al.
Kidney International Reports|April 29, 2021
Per-Treatment <i>Post Hoc</i> Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKDAndrew J Mallett, Ronald D Perrone, Gopala Rangan, et al.
Kidney International Reports|March 18, 2021
An Evaluation of Commonly Used Surrogate Baseline Creatinine Values to Classify AKI During Acute InfectionDaniel J Cooper, Katherine Plewes, Matthew J Grigg, et al.
Trials|March 14, 2023
PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)Toby J L Humphrey, Davinder Dosanjh, Thomas F Hiemstra, et al.
American Journal of Physiology. Renal Physiology|October 29, 2010
Glyceraldehyde 3-phosphate dehydrogenase is required for band 3 (anion exchanger 1) membrane residency in the mammalian kidneyYa Su, Katherine G Blake-Palmer, Andrew C Fry, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2015
α-Klotho Expression in Human TissuesKenneth Lim, Arnoud Groen, Guerman Molostvov, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2025
Pharmaceutical Practice Considerations Regarding Adoption of the Race-Free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 EquationsRuth Tarzi, Jennifer McKenzie, Michel Reid, et al.
Pageof 5